[Levothyrox : time of reason].

Rev Prat

Professeurs d'endocrinologie (hôpital Cochin [Paris], hôpital Foch [Suresnes], groupe hospitalier La Pitié-Salpêtrière [Paris], hôpital Claude-Huriez [Lille], CHRU Bicêtre [Le Kremlin-Bicêtre]).

Published: February 2018

Download full-text PDF

Source

Publication Analysis

Top Keywords

[levothyrox time
4
time reason]
4
[levothyrox
1
reason]
1

Similar Publications

A holistic AI-based approach for pharmacovigilance optimization from patients behavior on social media.

Artif Intell Med

October 2023

SMART Lab, New York University Abu Dhabi, Saadiyat Island, Abu Dhabi, PO Box 129188, United Arab Emirates. Electronic address:

In this paper, we propose a holistic AI-based pharmacovigilance optimization approach using patient's social media data. Instead of focusing on the detection and identification of Adverse Drug Events (ADE) in social media posts in single time points, we propose a holistic approach that looks at the evolution of different user behavior indicators in time. We examine various NLP-based indicators such as word frequency, semantic similarity, Adverse Drug Reactions mentions, and sentiment analysis.

View Article and Find Full Text PDF

Partial Versus Total Thyroidectomy: What Influences Most Surgeons' Decision? Analysis of a Nationwide Cohort of 375,810 Patients Over 10 Years.

Ann Surg

November 2021

General and Endocrine Surgery Department, Lille University Hospital CHU Lille, Lille, France; Inserm, U1190 Recherche translationnelle sur le diabète (EGID), Lille University Univ.Lille, Lille, France.

Article Synopsis
  • * This study aimed to examine factors influencing the choice between total and partial thyroidectomy, irrespective of the thyroid condition's severity.
  • * An analysis of over 375,000 thyroid surgery patients revealed increasing partial thyroidectomies correlated with new recommendations and specific patient factors like obesity and cancer type significantly affected surgical choices.
View Article and Find Full Text PDF

[Levothyrox : time of reason].

Rev Prat

February 2018

Professeurs d'endocrinologie (hôpital Cochin [Paris], hôpital Foch [Suresnes], groupe hospitalier La Pitié-Salpêtrière [Paris], hôpital Claude-Huriez [Lille], CHRU Bicêtre [Le Kremlin-Bicêtre]).

View Article and Find Full Text PDF
Article Synopsis
  • The new levothyroxine (L-T4) formulation meets stricter potency specifications, ensuring safe thyroid hormone levels for patients.
  • Bioequivalence studies show that the new formulation performs similarly to the current version, with both AUC and maximum concentration results within acceptable limits.
  • Dosage form proportionality is established across different tablet strengths, confirming that the new formulation’s various dosages are effective and consistent.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!